Skip to main content

PNEUMOSIL®

Product overview

Vaccine type
Pneumococcal (conjugate)
Commercial Name
PNEUMOSIL®
Manofacturer
Serum Institute of India Pvt. Ltd.
Responsible NRA
Central Drugs Standard Control Organization
Country
India

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
5
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
Carton of 50 vials (250 doses)(35 and 40 mm vial height) [Dimensions: 5.0 x 9.5 x 18.5 cm]
Tertiary Packaging
Box containing 4 cartons of 300 vials (1200 vials/ 60 000 doses)[Dimensions: 36 x 48 x 60 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.005%
Cold Chain Volume
3.515 cm3/dose (in secondary packaging)

Attachments

VPSAR (Vaccine Public Summary Assessment Report)
Container Photo
Container Photo
Package Insert
Package Insert